Country | N | HLA-G 14-bp allele | HLA-G 14-bp genotype | HWE p | Reference | |||
---|---|---|---|---|---|---|---|---|
Ins | Del | Ins/Ins | Ins/Del | Del/Del | ||||
Iraq | 100 | 82 (41.0) | 118 (59.0) | 20 (20.0) | 42 (42.0) | 38 (38.0) | 0.187 | Present study |
Algeria | 100 | 77 (38.5) | 123 (61.5) | 15 (15.0) | 47 (47.0) | 38 (38.0) | 0.940 | [22] |
Brazil | 120 | 107 (44.6) | 133 (55.4) | 26 (21.7) | 55 (45.8) | 39 (32.5) | 0.427 | [23] |
China | 292 | 193 (33.1) | 391(66.9) | 35 (12.0) | 123 (42.1) | 134 (45.9) | 0.411 | [24] |
Egypt | 100 | 120 (60.0) | 80 (40.0) | 38 (38.0) | 44 (44.0) | 18 (18.0) | 0.401 | [25] |
Greece | 192 | 176 (45.8) | 208 (54.2) | 39 (20.3) | 98 (51.0) | 55 (28.7) | 0.698 | [26] |
India | 383 | 347 (45.3) | 419 (54.7) | 86 (22.4) | 175 (45.7) | 122 (31.9) | 0.127 | [27] |
Iran | 210 | 180 (42.9) | 240 (57.1) | 52 (24.8) | 76 (36.2) | 82 (39.0) | < 0.001 | [28] |
Italy | 451 | 351 (38.9) | 551 (61.1) | 65 (14.4) | 221 (49.0) | 165 (36.6) | 0.514 | [29] |
Japan | 777 | 389 (25.0) | 1165 (75.0) | 58 (7.5) | 273 (35.1) | 446 (57.4) | 0.075 | [30] |
Korea | 491 | 232 (23.6) | 750 (76.4) | 17 (3.5) | 198 (40.3) | 276 (56.2) | 0.009 | [31] |
Mexico | 214 | 195 (45.6) | 233 (54.4) | 41 (19.2) | 113 (52.8) | 60 (28.0) | 0.346 | [32] |
Poland | 465 | 385 (41.4) | 545 (58.6) | 77 (16.5) | 231(49.7) | 157 (33.8) | 0.607 | [33] |
Saudi Arabia | 119 | 117 (49.2) | 121 (50.8) | 27 (22.7) | 63 (52.9) | 29 (24.4) | 0.519 | [34] |
Spain | 33 | 17 (25.8) | 49 (74.2) | 2 (6.1) | 13 (39.4) | 18 (54.5) | 0.863 | [35] |
Tunisia | 170 | 174 (51.2) | 166 (48.8) | 42 (24.7) | 90 (52.9) | 38 (22.4) | 0.439 | [36] |
Turkey | 191 | 188 (49.2) | 194 (50.8) | 48 (25.1) | 92 (48.2) | 51 (26.7) | 0.615 | [37] |
p | < 0.001 | < 0.001 |